1-Carmona L, Ballina J, Gabriel R, Laffon A.(2001) EPISER Study Group. The burden of musculoskeletal diseases in the general population of Spain: results from a national survey. Ann Rheum Dis 2001;60:1040e5.
2-Benedetti S, Canino C, Tonti G, Medda V, Calcaterra P, Nappi G, Salaffi F, Canestrari F. (2010): Biomarkers of oxidation, inflammation and cartilage degradation in osteoarthritis patients undergoing sulfur-based spatherapies. ClinBiochem.; 43: 973-8.
3-Fenton, S. A. M., Veldhuijzen van Zanten, J. J. C. S., Duda, J. L., Metsios, G. S., and Kitas, G. D. (2018). Sedentary behaviour in rheumatoid arthritis: definition, measurement and implications for health. Rheumatology. (Oxford) 57(2), 213-226.
4-Scott, D. L. (2007). Early rheumatoid arthritis. Br. Med. Bull. 81-82, 97-114.
5-Yoshihara, Y., Nakamura, H., Obata, K., Yamada, H., Hayakawa, T., Fujikawa, K., and Okada, Y. (2000). Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann. Rheum. Dis. 59(6), 455-461.
6-Kevorkian, L., Young, D. A., Darrah, C., Donell, S. T., Shepstone, L., Porter, S., Brockbank, S. M., Edwards, D. R., Parker, A. E., and Clark, I. M. (2004). Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 50(1), 131-141.
7-Murphy, G., and Nagase, H. (2008). Progress in matrix metalloproteinase research. Mol. Aspects Med. 29(5), 290-308.
8-Bonnans, C., Chou, J., and Werb, Z. (2014). Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15(12), 786-801.
9-Murphy, G., Knauper, V., Atkinson, S., Butler, G., English, W., Hutton, M., Stracke, J., and Clark, I. (2002a). Matrix metalloproteinases in arthritic disease. Arthritis Res. 4 Suppl 3, S39-S49.
10-Posthumus, M. D., Limburg, P. C., Westra, J., van Leeuwen, M. A., and van Rijswijk, M. H. (2000). Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression. J. Rheumatol. 27(12), 2761-2768.
11- Hofman, K., Hall, B., Cleaver, H., & Marshall, S. (2011): High-throughput quantification of hydroxyproline for determination of collagen. Analytical biochemistry, 417(2), 289-291.
12-Barranco, C. (2015): Osteoarthritis: activate autophagy to prevent cartilage degeneration? Nat. Rev. Rheumatol. 11, 127.
13-Naito, K., Takahashi, M., Kushida, K., Suzuki, M., Ohishi, T., Miura, M., ... & Nagano, A. (1999): Measurement of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in patients with knee osteoarthritis: comparison with generalized osteoarthritis. Rheumatology (Oxford, England), 38(6), 510-515.
14-M.S. Radha and Dr. M.R. Gangadhar (2015), Serum enzyme of matrix metalloproteinase-3 in patients with knee osteoarthritis, International Journal of Recent Scientific Research Vol. 6, Issue, 6, pp.4457-4460, June, 2015 .
15-Lohmander L.S.; Brandt K.D.; Mazzuca S.A.; Katz B.P.; Larsson S.; Struglics A. and Lane K.A. (2005): Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis. Arthritis Rheum. Vol.52, pp. 3160-3167.
16-Bassiouni, H. M., El-Deeb, M., Kenawy, N., Abdul-Azim, E., & Khairy, M. (2011). Phonoarthrography, musculoskeletal ultrasonography, and biochemical biomarkers for the evaluation of knee cartilage in osteoarthritis. Modern rheumatology, 21(5), 500-508.
17-Takahashi, M., Naito, K., Abe, M., et al (2004). Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Res Ther, 6(3), R208.
18-Thompson, P. W., Spector, T. D., James, I. T., Henderson, E., & Hart, D. J. (1992) :Urinary collagen crosslinks reflect the radiographic severity of knee osteoarthritis. Rheumatology, 31(11), 759-761.
19-Otterness, I. G., Weiner, E., Swindell, A. C., Zimmerer, R. O., Ionescu, M., & Poole, A. R. (2001) :An analysis of 14 molecular markers for monitoring osteoarthritis. Relationship of the markers to clinical end-points. Osteoarthritis and cartilage, 9(3), 224-231.
20-Ahmed, U., Anwar, A., Savage, R. S., Costa, M. L., Mackay, N., Filer, A., Raza, K., Watts, R. A., Winyard, P. G., Tarr, J., Haigh, R. C., Thornalley, P. J., and Rabbani, N. (2015). Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health. Sci. Rep. 5, 9259.